These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1023246)

  • 21. A combined study on the distribution of oxytetracycline and polyvinylpyrrolidone in rats.
    Hespe W; Blankwater YJ; Wieriks J
    Arzneimittelforschung; 1975 Oct; 25(10):1561-7. PubMed ID: 1243038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interactions.
    Rowland M
    Adv Biol Skin; 1972; 12():235-55. PubMed ID: 4579195
    [No Abstract]   [Full Text] [Related]  

  • 23. [The solubility of drugs in molten suppository bases].
    Pflegel P; Schöbel H; Klaus T; Raguse U
    Pharmazie; 1990 Apr; 45(4):266-7. PubMed ID: 2381978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlations between macromolecular adjuvants and drugs].
    Keipert S; Becker J; Schultze HH; Voigt R
    Pharmazie; 1973 Mar; 28(3):145-83. PubMed ID: 4573486
    [No Abstract]   [Full Text] [Related]  

  • 25. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
    Smith JS; Macrae RJ; Snowden MJ
    Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antidiabetics-antacid interactions.
    Naggar VF; Khalil SA
    Pharmazie; 1980; 35(7):412-6. PubMed ID: 7413713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies on the study of drug-excipient interactions with vapor pressure osmometry and equilibrium dialysis].
    Voigt R; Pergande G; Keipert S
    Pharmazie; 1984 Nov; 39(11):760-3. PubMed ID: 6531380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorption properties of cross-linked insoluble polyvinylpyrrolidone.
    Frömming KH; Ditter W; Horn D
    J Pharm Sci; 1981 Jul; 70(7):738-43. PubMed ID: 7264917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone.
    Karavas E; Ktistis G; Xenakis A; Georgarakis E
    Eur J Pharm Biopharm; 2006 Jun; 63(2):103-14. PubMed ID: 16675209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxytetracycline plasma concentrations in sheep after the administration of a polyvinylpyrrolidone formulation.
    Immelman A; Van Rensburg JJ
    J S Afr Vet Assoc; 1983 Dec; 54(4):241-2. PubMed ID: 6668572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
    Govindarajan R; Nagarsenker MS
    J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the problem of prolongating tetracycline hydrochloride, oxytetracycline and monomycin effect with polyvinylpyrrolidone aqueous solutions].
    Kochetkova VA; Berkengeĭm GB; Sidel'kovskaia FP
    Antibiotiki; 1967 Apr; 12(4):301-6. PubMed ID: 4869329
    [No Abstract]   [Full Text] [Related]  

  • 35. The dissolution kinetics of sulfamethoxazol, trimethoprim and oxytetracycline hydrochloride from multicomponent solid dispersion capsules ("Sulfoxytrim").
    Zuń M; Czarnecki W
    Acta Pol Pharm; 2000; 57(2):97-100. PubMed ID: 10934786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
    Friedrich H; Fussnegger B; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
    Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution mechanisms of drug-polyvinylpyrrolidone coprecipitates in aqueous solution.
    Sekikawa H; Nakano M; Arita T
    Chem Pharm Bull (Tokyo); 1979 May; 27(5):1223-30. PubMed ID: 498375
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro study of some factors influencing the diffusion of oxytetracycline chloride from hard gelatin capsules].
    Mura PA; Mazzi G; Liguori A; Bramanti G; Papini P
    Boll Chim Farm; 1984 Jul; 123(7):344-51. PubMed ID: 6518093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.